Hilsenbeck S - Search Results

1

Comparison of three tumor markers--CA-125, lipid-associated sialic acid (LSA), and NB/70K--in monitoring ovarian cancer.

Petru E, Sevin BU, Averette HE, Koechli OR, Perras JP, Hilsenbeck S. Petru E, et al. Among authors: hilsenbeck s. Gynecol Oncol. 1990 Aug;38(2):181-6. doi: 10.1016/0090-8258(90)90037-l. Gynecol Oncol. 1990. PMID: 2387533 Free article.

2

Microinvasive carcinoma of the cervix.

Sevin BU, Nadji M, Averette HE, Hilsenbeck S, Smith D, Lampe B. Sevin BU, et al. Among authors: hilsenbeck s. Cancer. 1992 Oct 15;70(8):2121-8. doi: 10.1002/1097-0142(19921015)70:8<2121::aid-cncr2820700819>3.0.co;2-s. Cancer. 1992. PMID: 1394041 Review.

3

The prognostic significance of surgical staging for carcinoma of the endometrium.

Wolfson AH, Sightler SE, Markoe AM, Schwade JG, Averette HE, Ganjei P, Hilsenbeck SG. Wolfson AH, et al. Among authors: hilsenbeck sg. Gynecol Oncol. 1992 May;45(2):142-6. doi: 10.1016/0090-8258(92)90276-o. Gynecol Oncol. 1992. PMID: 1592280

4

Long-term survival in stage III and IV ovarian cancer.

Petru E, Sevin BU, Averette HE, Koechli OR, Hilsenbeck S. Petru E, et al. Among authors: hilsenbeck s. Arch Gynecol Obstet. 1991;249(2):87-93. doi: 10.1007/BF02390367. Arch Gynecol Obstet. 1991. PMID: 1953056

5

Comparative efficacy of short-term versus long-term cefoxitin prophylaxis against postoperative infection after radical hysterectomy: a prospective study.

Sevin BU, Ramos R, Gerhardt RT, Guerra L, Hilsenbeck S, Averette HE. Sevin BU, et al. Among authors: hilsenbeck s. Obstet Gynecol. 1991 May;77(5):729-34. Obstet Gynecol. 1991. PMID: 2014087 Clinical Trial.

6

Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line.

Boike GM, Petru E, Sevin BU, Averette HE, Chou TC, Penalver M, Donato D, Schiano M, Hilsenbeck SG, Perras J. Boike GM, et al. Among authors: hilsenbeck sg. Gynecol Oncol. 1990 Sep;38(3):315-22. doi: 10.1016/0090-8258(90)90065-s. Gynecol Oncol. 1990. PMID: 2121626 Free article.

7

Prognostic factors of early stage cervical cancer treated by radical hysterectomy.

Sevin BU, Nadji M, Lampe B, Lu Y, Hilsenbeck S, Koechli OR, Averette HE. Sevin BU, et al. Among authors: hilsenbeck s. Cancer. 1995 Nov 15;76(10 Suppl):1978-86. doi: 10.1002/1097-0142(19951115)76:10+<1978::aid-cncr2820761313>3.0.co;2-k. Cancer. 1995. PMID: 8634988

8

The increasing recognition of adenosquamous lung carcinoma (1977-1986).

Sridhar KS, Raub WA Jr, Duncan RC, Hilsenbeck S. Sridhar KS, et al. Among authors: hilsenbeck s. Am J Clin Oncol. 1992 Aug;15(4):356-62. doi: 10.1097/00000421-199208000-00018. Am J Clin Oncol. 1992. PMID: 1514535

9

Toxicity of FED chemotherapy in non-small-cell lung cancer.

Sridhar KS, Varki J, Donnelly E, Davila E, Benedetto P, Hilsenbeck S, Thurer RJ, Rao RK, Fountzilas G, Beattie EJ. Sridhar KS, et al. Among authors: hilsenbeck s. Am J Clin Oncol. 1987 Dec;10(6):499-506. doi: 10.1097/00000421-198712000-00008. Am J Clin Oncol. 1987. PMID: 2446489

10

Lung carcinoma in 1,336 patients.

Sridhar KS, Raub W Jr, Duncan RC, Hilsenbeck S, Richman SP. Sridhar KS, et al. Among authors: hilsenbeck s. Am J Clin Oncol. 1991 Dec;14(6):496-508. doi: 10.1097/00000421-199112000-00008. Am J Clin Oncol. 1991. PMID: 1957838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters